DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹8,629 Cr | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr | ₹5,062 Cr |
What is the latest Net Current Assets ratio of DIVIS LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹8,629 Cr |
| Mar2024 | ₹8,397 Cr |
| Mar2023 | ₹8,211 Cr |
| Mar2022 | ₹7,156 Cr |
| Mar2021 | ₹5,062 Cr |
How is Net Current Assets of DIVIS LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,629 Cr | 2.76 | |
| Mar2024 | ₹8,397 Cr | 2.27 | |
| Mar2023 | ₹8,211 Cr | 14.74 | |
| Mar2022 | ₹7,156 Cr | 41.36 | |
| Mar2021 | ₹5,062 Cr | - | |
Compare Net Current Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹172,877.7 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| CIPLA | ₹123,722.0 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
| MANKIND PHARMA | ₹93,568.2 Cr | 1.4% | -6.9% | -15.2% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.7% |
-0.7% |
11% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses